BE591433A - Composition pharmaceutique à base de nicotinamide. - Google Patents
Composition pharmaceutique à base de nicotinamide.Info
- Publication number
- BE591433A BE591433A BE591433A BE591433A BE591433A BE 591433 A BE591433 A BE 591433A BE 591433 A BE591433 A BE 591433A BE 591433 A BE591433 A BE 591433A BE 591433 A BE591433 A BE 591433A
- Authority
- BE
- Belgium
- Prior art keywords
- nicotinamide
- pharmaceutical composition
- composition based
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US819231A US3070508A (en) | 1959-06-10 | 1959-06-10 | Method for rendering nicotinamide palatable |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE591433A true BE591433A (fr) | 1960-12-01 |
Family
ID=25227552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE591433A BE591433A (fr) | 1959-06-10 | 1960-06-01 | Composition pharmaceutique à base de nicotinamide. |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US3070508A (fr) |
| BE (1) | BE591433A (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313686A (en) * | 1962-08-24 | 1967-04-11 | Squibb & Sons Inc | Palatable antitussive agent-resin complex |
| US5219563A (en) * | 1988-05-11 | 1993-06-15 | Glaxo Group Limited | Drug adsorbates |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| US6403642B1 (en) | 1999-08-16 | 2002-06-11 | Pq Holding, Inc. | Sulfur adsorbent for reducing onion or garlic breath odor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2673827A (en) * | 1950-11-03 | 1954-03-30 | Lilly Co Eli | Therapeutic ion exchange resin mixture |
| US2697059A (en) * | 1951-01-22 | 1954-12-14 | Edwin L Gustus | Hydroxy aromatic carboxylate-resin adsorption composition |
| US2830933A (en) * | 1955-07-14 | 1958-04-15 | Pfizer & Co C | Vitamin b12 products and preparation thereof |
| US2990332A (en) * | 1958-04-02 | 1961-06-27 | Wallace & Tiernan Inc | Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith |
-
1959
- 1959-06-10 US US819231A patent/US3070508A/en not_active Expired - Lifetime
-
1960
- 1960-06-01 BE BE591433A patent/BE591433A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US3070508A (en) | 1962-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE591341A (fr) | Compositions à base de verre. | |
| BE592524A (fr) | Table à répertorier. | |
| FR1248186A (fr) | Fongicides à noyau 1,2-dithiolique | |
| BE591433A (fr) | Composition pharmaceutique à base de nicotinamide. | |
| CH385487A (fr) | Composition à base de polyoxyméthylène | |
| DK108209C (da) | Brevordner. | |
| BE588040A (fr) | Régule à base de cuivre-zinc-aluminium. | |
| OA01058A (fr) | Enduit à base de résine. | |
| BE589109A (fr) | Compositions à base de cobalamine. | |
| FR1247074A (fr) | Agencement sur chariots élévateurs à fourche | |
| BE597506A (fr) | Composés à base de nitropyridine. | |
| BE591434A (fr) | Composition pharmaceutique à base de thiamine. | |
| FR1291544A (fr) | Produits anti-parasitaires à base de nitro-halogéno-benzonitriles | |
| FR663M (fr) | Médicament à base de dithiosemicarbazones | |
| FR1249298A (fr) | Meuble à langer | |
| FR2557M (fr) | Composition pharmaceutique. | |
| OA00336A (fr) | Meuble de laboratoire. | |
| BE573527R (fr) | Commutateur à coordonnées (coordinaatschakelaar). | |
| FR2204M (fr) | Nouvelle composition pharmaceutique a base de stéroides. | |
| BE597016A (fr) | Alliage à base de columbium | |
| BE589207A (fr) | Composition à base de cobalamine. | |
| FR168M (fr) | Composition progestinogene a base de 17-acétate de 6alpha-méthyl-17alpha-hydroxy-progestérone. | |
| FR282M (fr) | Médicaments corticostéroides. | |
| FR94M (fr) | Nouveau médicament à base de levure vivante | |
| FR1175028A (fr) | Alliage à base de chrome-cobalt |